CN106490605A - A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof - Google Patents
A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof Download PDFInfo
- Publication number
- CN106490605A CN106490605A CN201611209082.6A CN201611209082A CN106490605A CN 106490605 A CN106490605 A CN 106490605A CN 201611209082 A CN201611209082 A CN 201611209082A CN 106490605 A CN106490605 A CN 106490605A
- Authority
- CN
- China
- Prior art keywords
- parts
- hypertension
- pregnancy
- powder
- tailored version
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 66
- 230000035935 pregnancy Effects 0.000 title claims abstract description 55
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 48
- 230000035764 nutrition Effects 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 238000009472 formulation Methods 0.000 title abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract description 36
- 239000011782 vitamin Substances 0.000 claims abstract description 36
- 235000012054 meals Nutrition 0.000 claims abstract description 35
- 230000035622 drinking Effects 0.000 claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- 235000008216 herbs Nutrition 0.000 claims abstract description 29
- 230000010354 integration Effects 0.000 claims abstract description 29
- 235000013305 food Nutrition 0.000 claims abstract description 25
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 24
- 241000196324 Embryophyta Species 0.000 claims abstract description 23
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 23
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 23
- 150000001875 compounds Chemical class 0.000 claims abstract description 22
- 229940088594 vitamin Drugs 0.000 claims abstract description 21
- 229930003231 vitamin Natural products 0.000 claims abstract description 21
- 235000013343 vitamin Nutrition 0.000 claims abstract description 21
- 239000011573 trace mineral Substances 0.000 claims abstract description 19
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 19
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 15
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 15
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract description 14
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 14
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 14
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 14
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 13
- 241000219784 Sophora Species 0.000 claims abstract description 13
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 12
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 12
- 241000237502 Ostreidae Species 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims abstract description 12
- 235000020636 oyster Nutrition 0.000 claims abstract description 12
- 244000119298 Emblica officinalis Species 0.000 claims abstract description 11
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 9
- 239000003094 microcapsule Substances 0.000 claims abstract description 9
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims description 103
- -1 phytosterol Chemical compound 0.000 claims description 13
- 241000251468 Actinopterygii Species 0.000 claims description 11
- 235000019688 fish Nutrition 0.000 claims description 11
- 241000972773 Aulopiformes Species 0.000 claims description 10
- 244000000626 Daucus carota Species 0.000 claims description 10
- 235000002767 Daucus carota Nutrition 0.000 claims description 10
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 10
- 241000287420 Pyrus x nivalis Species 0.000 claims description 10
- 235000011453 Vigna umbellata Nutrition 0.000 claims description 10
- 240000001417 Vigna umbellata Species 0.000 claims description 10
- 235000019515 salmon Nutrition 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 9
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 8
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 8
- 240000005250 Chrysanthemum indicum Species 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 5
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 5
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 3
- 244000061456 Solanum tuberosum Species 0.000 claims description 3
- 235000013339 cereals Nutrition 0.000 claims description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 2
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 claims description 2
- 241000238557 Decapoda Species 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- 241000208688 Eucommia Species 0.000 claims description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 2
- 244000179886 Moringa oleifera Species 0.000 claims description 2
- 235000011347 Moringa oleifera Nutrition 0.000 claims description 2
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims description 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 2
- 235000010081 allicin Nutrition 0.000 claims description 2
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 claims description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 2
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 2
- 235000020243 first infant milk formula Nutrition 0.000 claims description 2
- 229930003944 flavone Natural products 0.000 claims description 2
- 150000002213 flavones Chemical class 0.000 claims description 2
- 235000011949 flavones Nutrition 0.000 claims description 2
- 229960002442 glucosamine Drugs 0.000 claims description 2
- 235000012680 lutein Nutrition 0.000 claims description 2
- 229960005375 lutein Drugs 0.000 claims description 2
- 239000001656 lutein Substances 0.000 claims description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 2
- 235000012661 lycopene Nutrition 0.000 claims description 2
- 229960004999 lycopene Drugs 0.000 claims description 2
- 239000001751 lycopene Substances 0.000 claims description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 2
- 235000021283 resveratrol Nutrition 0.000 claims description 2
- 229940016667 resveratrol Drugs 0.000 claims description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims 1
- 229920002498 Beta-glucan Polymers 0.000 claims 1
- 240000008620 Fagopyrum esculentum Species 0.000 claims 1
- 235000013372 meat Nutrition 0.000 claims 1
- 244000144977 poultry Species 0.000 claims 1
- 238000007873 sieving Methods 0.000 claims 1
- 230000036772 blood pressure Effects 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 17
- 235000015097 nutrients Nutrition 0.000 abstract description 11
- 206010070538 Gestational hypertension Diseases 0.000 abstract description 6
- 201000005624 HELLP Syndrome Diseases 0.000 abstract description 6
- 208000005347 Pregnancy-Induced Hypertension Diseases 0.000 abstract description 6
- 208000036335 preeclampsia/eclampsia 1 Diseases 0.000 abstract description 6
- 230000009467 reduction Effects 0.000 abstract description 6
- 210000003754 fetus Anatomy 0.000 abstract description 5
- 238000011161 development Methods 0.000 abstract description 4
- 238000012216 screening Methods 0.000 abstract description 2
- 238000000227 grinding Methods 0.000 abstract 1
- 235000013350 formula milk Nutrition 0.000 description 25
- 235000010469 Glycine max Nutrition 0.000 description 24
- 239000000839 emulsion Substances 0.000 description 24
- 244000068988 Glycine max Species 0.000 description 23
- 235000019197 fats Nutrition 0.000 description 19
- 235000018102 proteins Nutrition 0.000 description 19
- 239000003921 oil Substances 0.000 description 18
- 235000019198 oils Nutrition 0.000 description 18
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 18
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 16
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 16
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 16
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 16
- 150000003722 vitamin derivatives Chemical class 0.000 description 14
- 229920002774 Maltodextrin Polymers 0.000 description 13
- 239000005913 Maltodextrin Substances 0.000 description 13
- 229940035034 maltodextrin Drugs 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 235000013312 flour Nutrition 0.000 description 10
- 241000219051 Fagopyrum Species 0.000 description 9
- 102000015636 Oligopeptides Human genes 0.000 description 9
- 108010038807 Oligopeptides Proteins 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 239000004006 olive oil Substances 0.000 description 9
- 235000008390 olive oil Nutrition 0.000 description 9
- 229960003080 taurine Drugs 0.000 description 9
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 8
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 8
- 229920000858 Cyclodextrin Polymers 0.000 description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 8
- 239000004375 Dextrin Substances 0.000 description 8
- 229920001353 Dextrin Polymers 0.000 description 8
- 229920001202 Inulin Polymers 0.000 description 8
- 229920002752 Konjac Polymers 0.000 description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 8
- 240000003183 Manihot esculenta Species 0.000 description 8
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 8
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 8
- 235000004347 Perilla Nutrition 0.000 description 8
- 244000124853 Perilla frutescens Species 0.000 description 8
- 229920000294 Resistant starch Polymers 0.000 description 8
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 8
- 229930003268 Vitamin C Natural products 0.000 description 8
- 229930003427 Vitamin E Natural products 0.000 description 8
- 239000005862 Whey Substances 0.000 description 8
- 108010046377 Whey Proteins Proteins 0.000 description 8
- 102000007544 Whey Proteins Human genes 0.000 description 8
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 8
- 235000013734 beta-carotene Nutrition 0.000 description 8
- 239000011648 beta-carotene Substances 0.000 description 8
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 8
- 229960002747 betacarotene Drugs 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 239000003240 coconut oil Substances 0.000 description 8
- 235000019864 coconut oil Nutrition 0.000 description 8
- 235000021277 colostrum Nutrition 0.000 description 8
- 210000003022 colostrum Anatomy 0.000 description 8
- 235000019425 dextrin Nutrition 0.000 description 8
- 239000000835 fiber Substances 0.000 description 8
- 229960000304 folic acid Drugs 0.000 description 8
- 235000019152 folic acid Nutrition 0.000 description 8
- 239000011724 folic acid Substances 0.000 description 8
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 8
- 150000003271 galactooligosaccharides Chemical class 0.000 description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 8
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 8
- 229940029339 inulin Drugs 0.000 description 8
- 229910052742 iron Inorganic materials 0.000 description 8
- 239000008101 lactose Substances 0.000 description 8
- 229960003512 nicotinic acid Drugs 0.000 description 8
- 235000001968 nicotinic acid Nutrition 0.000 description 8
- 239000011664 nicotinic acid Substances 0.000 description 8
- 229940055726 pantothenic acid Drugs 0.000 description 8
- 235000019161 pantothenic acid Nutrition 0.000 description 8
- 239000011713 pantothenic acid Substances 0.000 description 8
- 235000021254 resistant starch Nutrition 0.000 description 8
- 239000011435 rock Substances 0.000 description 8
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 8
- 239000003549 soybean oil Substances 0.000 description 8
- 235000012424 soybean oil Nutrition 0.000 description 8
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 8
- 235000019155 vitamin A Nutrition 0.000 description 8
- 239000011719 vitamin A Substances 0.000 description 8
- 239000011726 vitamin B6 Substances 0.000 description 8
- 235000019154 vitamin C Nutrition 0.000 description 8
- 239000011718 vitamin C Substances 0.000 description 8
- 235000019165 vitamin E Nutrition 0.000 description 8
- 239000011709 vitamin E Substances 0.000 description 8
- 229940046009 vitamin E Drugs 0.000 description 8
- 229940045997 vitamin a Drugs 0.000 description 8
- 235000008939 whole milk Nutrition 0.000 description 8
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 8
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 7
- 108010035532 Collagen Proteins 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 7
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 7
- 229930003316 Vitamin D Natural products 0.000 description 7
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 229960005069 calcium Drugs 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 235000014633 carbohydrates Nutrition 0.000 description 7
- 229920001436 collagen Polymers 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- 239000003292 glue Substances 0.000 description 7
- 230000007062 hydrolysis Effects 0.000 description 7
- 238000006460 hydrolysis reaction Methods 0.000 description 7
- 239000011630 iodine Substances 0.000 description 7
- 229910052740 iodine Inorganic materials 0.000 description 7
- 239000011777 magnesium Substances 0.000 description 7
- 229910052749 magnesium Inorganic materials 0.000 description 7
- 229940091250 magnesium supplement Drugs 0.000 description 7
- 239000011574 phosphorus Substances 0.000 description 7
- 229910052698 phosphorus Inorganic materials 0.000 description 7
- 239000011591 potassium Substances 0.000 description 7
- 229910052700 potassium Inorganic materials 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 235000019166 vitamin D Nutrition 0.000 description 7
- 239000011710 vitamin D Substances 0.000 description 7
- 150000003710 vitamin D derivatives Chemical class 0.000 description 7
- 229940046008 vitamin d Drugs 0.000 description 7
- 239000011701 zinc Substances 0.000 description 7
- 229910052725 zinc Inorganic materials 0.000 description 7
- 229930006000 Sucrose Natural products 0.000 description 6
- 230000004872 arterial blood pressure Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000001077 hypotensive effect Effects 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- 208000001953 Hypotension Diseases 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 230000001804 emulsifying effect Effects 0.000 description 5
- 208000021822 hypotensive Diseases 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 240000009120 Phyllanthus emblica Species 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000004519 grease Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 201000011461 pre-eclampsia Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000011121 vaginal smear Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 206010001580 Albuminuria Diseases 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229910052793 cadmium Inorganic materials 0.000 description 2
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000003595 mist Substances 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000021049 nutrient content Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241000112528 Ligusticum striatum Species 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 1
- 241000488974 Loranthus Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 240000001740 Momordica dioica Species 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 108700023400 Platelet-activating factor receptors Proteins 0.000 description 1
- 241001300674 Plukenetia volubilis Species 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 102100028255 Renin Human genes 0.000 description 1
- 108090000783 Renin Proteins 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical compound [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000002416 angiotensin derivative Substances 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000021196 dietary intervention Nutrition 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 208000002296 eclampsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000009483 enzymatic pathway Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000003371 gabaergic effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 201000009939 hypertensive encephalopathy Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical group [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000003622 mature neutrocyte Anatomy 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004084 membrane receptors Proteins 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000009984 peri-natal effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 102000030769 platelet activating factor receptor Human genes 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 235000014393 valine Nutrition 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The present invention relates to a kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof, the present invention adopts 25 35 parts of protein, 8 15 parts of fat, 35 45 parts of carbohydrate, 38 parts of dietary fibers, 0.6 1.2 parts of macroelements, 0.01 0.03 parts of trace elements, 0.005 0.02 parts of liposoluble vitamins, 0.08 0.2 parts of water soluble vitamins, 0.5 5 parts of meals elite, 0.5 5 parts of integration of drinking and medicinal herbs compositions, 0.1 1 parts of natural plants compounds and 0.1 0.4 parts of new resource foods, wherein described integration of drinking and medicinal herbs composition is selected from chrysanthemum, the sophora bud, lotus leaf, matrimony vine, oyster, emblic, at least one in the root of kudzu vine;The previously prepared powdering of each component, wherein fat prepare powdered oil using micro-capsule embedding techniques.By screening and the proportioning of said components, nutrient formulation of the present invention can provide comprehensive nutritional need for pregnancy-induced hypertension patients, simultaneously by adding the component with blood pressure reduction effect, auxiliary reduces the pressure value of the hypertension of pregnancy, reduce the risk of the hypertension of pregnancy, it is ensured that needed for the growth of fetus and normal development.
Description
Technical field
The present invention relates to special medicine purposes formula food field, and in particular to a kind of clinical battalion of hypertension of pregnancy tailored version
Support formula and preparation method thereof.
Background technology
Hypertension of pregnancy synthetic disease is the gestational period distinctive disease, including gestation hypertension, preeclampsia and eclampsia
Deng, be mainly shown as blood pressure raise and albuminuria, each internal organs of pregnant woman can be endangered.Generally major part gestational patients only have slight
Symptom, but the consequence of some Disadvantage pregnancies can be caused, including premature labor, FGR, when serious, may result in foetal death, tire
Disk early stripping etc..In China, the incidence of disease about 9.4% of the hypertension of pregnancy, foreign countries about 7%~12%;Majority of cases is in gestation 20
There are the symptoms such as hypertension, albuminuria in Zhou Yihou, disappeared therewith after childbirth.The disease has a strong impact on baby's health, is pregnant
Puerpera and the main cause of perinatal feruses disease rate and the death rate.
With increasing for growth in the living standard, bad diet style and lying-in woman advanced in years, the gestation hypertension incidence of disease by
Year rises.The mode for the treatment of gestation hypertension is mainly Chinese medicine preparation or dietotherapy, such as Chinese patent at present
CN103893548A discloses a kind of Chinese medicine preparation for treating gestation hypertension disease, its raw material group by following percentage by weight
Into:Ligusticum wallichii 10-20%, root of kudzu vine 10-20%, parasitic loranthus 6-12%, bighead atractylodes rhizome 8-15%, sealwort 6-12%, hawthorn 10-20%, summer
Withered grass 6-12%, cucumber stem 6-12%, Poria cocos 8-16%, using the standby Chinese medicine capsules of this patent system to hypertension of pregnancy safety
Effectively, lossless fetus, but its nutrient content is not comprehensive.
In recent years report thinks, nutrient imbalance is closely related with PIH generation, therefore affects which by nutritional intervention
Raw, development, is a feasible approach.At present, pathogenic factor diseases, such as hypertension relevant with nutrition etc., can pass through nutrition
Intervene and reduce generation, delay of progression, confirmed by clinical practice.But have no applied nutrition intervening measure prevention preeclampsia so far
Research report.For this purpose, developing the special clinical nutrition formula of the hypertension of pregnancy, it is to prevent or alleviate preeclampsia, ensure that mother and baby is good for
The important channel of health.
Content of the invention
It is an object of the invention to overcoming defect of the prior art, there is provided a kind of hypertension of pregnancy tailored version clinical nutrition
Formula and preparation method thereof, hypertension of pregnancy tailored version clinical nutrition formula of the present invention is provided for pregnancy-induced hypertension patients
Comprehensively nutritional support, payes attention to comprehensive demand of the patient to basic energy, basic nutrition and essential trace element;And in this base
On plinth, add some hypotensive integration of drinking and medicinal herbs composition, natural plants compound and new resource foods, steady pregnant woman's blood pressure, solution
Certainly the problem of pregnancy-induced hypertension patients hypertension, realizes mother and sons' health safety.
For achieving the above object, the present invention is adopted the following technical scheme that:
On the one hand, the present invention provides a kind of hypertension of pregnancy tailored version clinical nutrition formula, including following parts by weight
Component:25-35 part protein, 8-15 parts fat, 35-45 part carbohydrate, 3-8 part dietary fibers, 0.6-1.2 parts constant unit
Element, 0.01-0.03 parts trace element, 0.005-0.02 part liposoluble vitamins, 0.08-0.2 part water soluble vitamins, 0.5-5
Part meals elite, 0.5-5 part integration of drinking and medicinal herbs compositions, 0.1-1 part natural plants compounds and 0.1-0.4 part new resource foods.
In order to further optimize above-mentioned technical proposal, the technical measures taken by the present invention also include:
Preferably, the protein is selected from PURE WHEY, soybean protein isolate, whole milk powder, dried whole-egg, newborn iron egg
In vain, at least one in colostrum, amino acid, protein peptides;
Wherein, the amino acid is selected from 1B-Pidolidone, mono- glutamic acid of L, mono- arginine of L, L-Trp, L mono-
At least one in glutamine, taurine, mono- valines of L, ILE, mono- leucines of L;The protein peptides are selected from soybean
In oligopeptide, wheat protein peptide, pupa albumen peptide, ocean fish oligopeptide powder, laughable peptide, amino peptide, ovalbumin peptide at least
A kind of.
Preferably, the fat includes saturated fatty acid, polyunsaturated fatty acid, monounsaturated fatty acids, OPO structures
At least one in fat, DHA, EPA, ARA, phosphatide, more specifically described fat include safflower seed oil, walnut oil, peanut oil,
Soybean oil, Ah's glycerine, olive oil, tea oil, oil and fat of sacha inchi, olive oil, coconut oil, perilla herb oil, deep sea fish oil, cupu oil, palm
Oil, butter, cream, lard, medium chain triglyceride, lecithin.
Preferably, the carbohydrate is included in fructose, rock sugar, lactose, maltodextrin, tapioca, resistant starch
At least two.
Preferably, the dietary fiber comprising inulin, konjaku flour, galactooligosaccharide, FOS, oligoisomaltose,
At least one in soybean polyoses, cyclodextrin, resistant dextrin, fibre and soya.
Preferably, the macroelement is selected from calcium citrate, L-calcium lactate, calcium monohydrogen phosphate, K-IAO, sodium citrate
With at least one in magnesium gluconate.
Preferably, the trace element is selected from ferrous gluconate, KI, zinc gluconate, sodium selenite, glucose
At least one in sour copper, chromium sulfate, manganese gluconate and sodium molybdate.
Preferably, the liposoluble vitamin is selected from vitamin A, beta carotene, vitamine D3, vitamin E, vitamin
At least one in K1.
Preferably, the water soluble vitamin is selected from vitamin B1, vitamin B2, vitamin B6, vitamin B12, dimension life
At least one in plain C, pantothenic acid, folic acid, nicotinic acid, choline, inositol, biotin.
Preferably, the meals elite is selected from cereal, beans, potato class, greengrocery, Homonemeae, nut-seed class, fishes and shrimps
At least one in class, poultry meat, fruits;Wherein described cereal mainly by rice meal, millet powder, black rice flour, coixlacrymajobi powder,
One kind in corn flour, wheat germ powder, oatmeal, buckwheat or at least two compositions, the beans is mainly by peameal, green
One kind in bean powder, black bean powder, red bean powder, soy meal or at least two compositions, the potato class are mainly made up of common yam rhizome powder, described
Vegetable powder is mainly by one kind in carrot meal, white radish powder, pumpkin powder, spinach powder, tomato meal, broccoli powder, balsam pear powder or several
Composition is planted, mainly by one or more in mushroom powder and white fungus powder, the nut-seed class is mainly lotus seeds to the Homonemeae
Powder, the fish and shrimp are mainly made up of one or more in salmon powder and cod meal, the poultry meat mainly by
In chicken meal, powdered beef one or more composition, the fruits mainly by red date powder, longan powder, apple powder, cherry powder,
One or more compositions in oranges and tangerines powder, snow pear powder;It is highly preferred that the meals elite by oatmeal, buckwheat, red bean powder,
Carrot meal, salmon powder, snow pear powder composition.
Preferably, the integration of drinking and medicinal herbs composition is selected from chrysanthemum, the sophora bud, lotus leaf, matrimony vine, oyster, emblic, the root of kudzu vine extremely
Few one kind.
Preferably, the natural plants compound is selected from l-cn, Glucosamine, FOS, lutein, plant
At least one in sterol, lycopene, resveratrol, allicin;The natural plants compound is more preferably l-cn.
Preferably, the new resource food is selected from first milk basic protein, GABA, chitosan oligosaccharide, eucommia Bark male flower, bamboo
At least one in leaf flavones, CPP, avenabeta glucosan, yeast beta-dextran, leaf of Moringa, xylo-oligosaccharide;Institute
State new resource food and be more preferably GABA.
Preferably, in the integration of drinking and medicinal herbs composition, the parts by weight of each component are as follows:Chrysanthemum 0-1 parts, sophora bud 0-1 parts, lotus
Leaf 0-1 parts, matrimony vine 0-1 parts, oyster 0-1 parts, emblic 0-1 parts, root of kudzu vine 0-1 parts.
Preferably, the good protein weight provided in the protein and amino acid accounts for the 70% of gross protein weight
More than.
Preferably, in the fat, the ratio of n-6 aliphatic acid and n-3 aliphatic acid is 3~4:1.
On the other hand, the present invention relates to a kind of by above-mentioned hypertension of pregnancy tailored version clinical nutrition formula prepare product,
Including nutrient powder, nutrition emulsion, capsule, tablet, pill, oral liquid etc..
Finally, the present invention is also provided and a kind of the hypertension of pregnancy tailored version clinical nutrition formula is prepared into nutrient powder
Method, its comprise the steps:By the protein of predetermined weight number, fat, carbohydrate, dietary fiber, macroelement,
Trace element, liposoluble vitamin, water soluble vitamin, meals elite, integration of drinking and medicinal herbs composition, natural plants compound and new
Resource food is prepared into the powdery that particle diameter is 100~300 μm respectively, and the powdery is well mixed, and obtains hypertension tailored version
Complete nourishing powder, filling after sterilization processing in packaging bag or is placed directly within pail pack;Wherein, the fat is using micro-
Capsule embedding techniques makes powder, and the integration of drinking and medicinal herbs composition makes powder by crushing, crossing 60-80 mesh sieves.
The present invention also provides a kind of side that the hypertension of pregnancy tailored version clinical nutrition formula is prepared into nutrition emulsion
Method, its comprise the steps:
Step one, by the protein of predetermined weight number, fat, carbohydrate, dietary fiber, macroelement, micro
Element, liposoluble vitamin, water soluble vitamin, meals elite, integration of drinking and medicinal herbs composition, natural plants compound and new resources
Food is prepared into the powdery that particle diameter is 100~300 μm respectively;Wherein, the fat makes powder using micro-capsule embedding techniques,
The integration of drinking and medicinal herbs composition makes powder by crushing, crossing 60-80 mesh sieves;
Step 2, protein powder is dissolved in a certain amount of water abundant aquation, obtains protein aqueous solution, then by carbon
Hydrate powder, macroelement powder, micro- powder, water soluble vitamin powder are dissolved in protein aqueous solution,
Obtain aqueous phase solution;
Step 3, by the fat powder after micro-capsule embedding treatment, liposoluble vitamin powder, meals elite powder, medicine food
Homologous component powders, natural plants compound powder sequentially add the aqueous phase solution of gained in step 2, and carry out strong agitation,
Add emulsifying agent and thickener, obtain concentrated emulsions;
Step 4, in the concentrated emulsions described in step 3 add scheduled volume water and stir, while removing skim-coat
Foam, obtains emulsion, then by emulsion homogeneous under high pressure, in high-temperature sterilization, is cooled to room temperature, and nutrition emulsion is obtained, and will
Nutrition emulsion is filling in packaging bag.
In above two preparation method, the specific implementation step of micro-capsule embedding techniques is as follows:By fat, emulsifying agent, wall
Material prepares emulsion with water mixed dissolution;After by the stirring mixing of above-mentioned emulsion, emulsifying homogeneous process is carried out, is then sprayed
Dry, screening prepares powdered oil, and powdered oil is compared with conventional grease, its dispersiveness, water solubility, emulsibility, non-oxidizability
All improve a lot;
Wherein, the emulsifying agent is selected from fatty acid glyceride (glyceride), methyl glycol fatty acid ester (propylene glycol ester), sorb
One or more in glycan fatty acid ester (sorbitan acid), sucrose fatty ester (sucrose ester), lecithin;The wall material choosing
From sodium carboxymethylcellulose, gelatin, carragheen, xanthans, Arabic gum, guar gum, maltodextrin, lipoprotein, corn syrup
In one or more.
Using the integration of drinking and medicinal herbs composition for including chrysanthemum, the sophora bud, lotus leaf, matrimony vine, oyster, emblic, the root of kudzu vine in the present invention, on
Stating composition has definite, safe blood pressure reduction effect.
Chrysanthemum has hypotensive, elimination cancer cell, coronary artery dilator and antibacterial effect, and drinking for a long time to increase human body
Calcareous, regulation myocardial function, reduction cholesterol;
The sophora bud contains abundant Quercetin and rutin, with hypotensive, reduction capillary permeability and fragility, antithrombotic
Deng effect.Wherein, Quercetin has than the effect of vitamin C more preferable endothelium-dependent relaxation vasodilator;Incidence of CHD can be reduced
And fatal rate, reduce atherosclerotic and coronary artery disease;Strengthen coronary artery circulation, prevent thrombosis;And rutin
Can adjust and reduce fragility of blood vessels, reduce vasopermeability, keep and recover the normal elasticity of capillary, prevent angiorrhoxis,
Auxiliary treatment for high blood pressure.Rutin in the sophora bud produces the blood of endothelium-dependent relaxation by NO- guanylates enzymatic pathway
Pipe diastole is acted on, can dose-dependant ground antagonism PAF and the specific binding of rabbit platelet membrane receptor, suppress PAF mediation rabbit blood little
Plate is sticked and is raised with free Ca2+ concentration in PMNs, and which passes through to suppress paf receptor activation, and then blocks the reaction of PAF inductions, from
And play antithrombotic effect;
Lotus leaf main component have Nuciferine, citric acid, malic acid, gluconic acid, oxalic acid, butanedioic acid and other anti-have silk point
The alkaline components of effect are split, there is antipyretic, antibacterial, spasmolysis, modern pharmacological research to show for which, lotus leaf has hypotensive, drop
Blood fat, effect of fat-reducing;
There is matrimony vine nourishing the liver, nourshing kidney, effect of moistening lung, the LBP-X which contains there is promotion immunity, anti-aging, resist and swell
The effects such as knurl, removing free radical, antifatigue, radioresistance, liver protection, reproductive function protection and improvement;
In oyster, contained abundant Taurine has obvious hepatic cholagogic effect, and this is also preventing and treating pregnancy period hepatic bile stasis of blood product
The good medicine of disease, contained abundant trace element and glycogen, to promoting growing, rescuing pregnant woman anemia and to pregnant woman's for fetus
Antisecosis is beneficial to, and which can also reduce and reduce harm of the hazardous trace elements cadmium to human body, can efficiently control and hinder
High blood pressure caused by disconnected cadmium, is conducive to improving and prevents and treats high blood pressure, prevent or alleviate hypertensive encephalopathy (as cerebral hemorrhage,
Cerebral thrombus) generation;
Emblic has clearing heat and cooling blood, and food digesting stomach fortifying is hypotensive, reducing blood lipid, and treatment cardiovascular and cerebrovascular disease has effect well
Really;Emblic fruit taste acid micro-puckery, clearing heat and cooling blood, digestion-promoting spleen-invigorating promote the production of body fluid to quench thirst, and which cures mainly blood-head blood stasis, indigestion, abdomen
Swollen, cough, laryngalgia, dry and vitamin C deficiency.In Tibetan medicine, emblic cures mainly sick Baconic, red bar disease, blood disease, hypertension
Disease etc.;
The root of kudzu vine has rising Yang expelling pathogenic factors from muscles and skin, promoting eruption antidiarrheal, effect that relieving restlessness is quenched the thirst.Modern pharmacological research shows contained by the root of kudzu vine
The total Pueraria lobota ketone of the root of kudzu vine and Puerarin significantly reduce can plasma renin activity and angiotensins, drop in blood pressure;
Compared with prior art, the invention has the advantages that:
(1) present invention adds the integration of drinking and medicinal herbs composition with hypotensive effect, and its each component complements each other, determined curative effect, tool
There is safe blood pressure reduction effect, which can provide required nutrient content for pregnancy-induced hypertension patients with other raw materials again jointly, protect
The normal development of card fetus;
(2) present invention adds the new resource food of the GABA with antihypertensive effect, and Gabanergic is direct
The vasomotor center of spinal cord is acted on, blood vessel dilatation is effectively facilitated, the purpose of blood pressure is reduced.
(3) present invention prepares powdered oil using micro-capsule embedding techniques so that powdered oil has preferable mobility, easily
In being well mixed with other powdered components;And using after micro-capsule embedding techniques, grease is embedded in wall material, so as to avoid with
The contact of air to strengthen non-oxidizability, so as to the maximum effect of health grease can be played.
(4) raw material of hypertension of pregnancy tailored version clinical nutrition formula of the present invention is made in preparation process in advance
For the powder into 100~300 μm, this is caused when finished product is prepared, and each nutrition composition can be well mixed, it is ensured that in unit volume
Each nutrition composition content essentially identical, while when liquid type preparation is prepared, each nutrition composition can be fully dispersed and complete
It is dissolved in solvent, prevents solids of sedimentation in liquid, occur, effect of finished product product has been effectively ensured.
Specific embodiment
The present invention provides a kind of hypertension of pregnancy tailored version with suppression blood glucose rise for pregnancy-induced hypertension patients
Enteral clinical nutrition is filled a prescription, including the component of following parts by weight:25-35 part protein, 8-15 parts fat, 35-45 part carbon water
Compound, 3-8 part dietary fibers, 0.6-1.2 part macroelements, 0.01-0.03 parts trace element, 0.005-0.02 parts are fat-soluble
Vitamin, 0.08-0.2 part water soluble vitamins, 0.5-5 part meals elite, 0.5-5 part integration of drinking and medicinal herbs compositions, 0.1-1 parts are natural
Plant compound and 0.1-0.4 part new resource foods.
With reference to embodiment, the specific embodiment of the present invention is further described.Following examples are only used for more
Plus technical scheme is clearly demonstrated, and can not be limited the scope of the invention with this.
Embodiment 1
Hypertension of pregnancy tailored version clinical nutrition formula of the present invention includes that PURE WHEY 11.3g, soybean separate
Albumen 4.33g, hydrolysis Isin glue collagen 0.66g, whole milk powder 12g, dried whole-egg 0.33g, colostrum 0.16, taurine 0.11g,
Ocean fish oligopeptide powder 0.266g;Olive oil 1.77g, soybean oil 4.48g, coconut oil 1.77g, perilla herb oil 2.64g, medium chain triglyceride
Three ester 0.213g;Maltodextrin 9.28g, rock sugar 8g, lactose 0.67g, tapioca 10g, resistant starch 13.33g;Dietary fiber
Selected from inulin, konjaku flour, galactooligosaccharide, FOS, oligoisomaltose, soybean polyoses, cyclodextrin, resistant dextrin, big
At least one in beans fiber, its gross mass be 4.99g, wherein water-soluble dietary fiber 3.83g, fat-soluble dietary fiber
1.16g;Calcium 0.4g, phosphorus 0.25g, potassium 0.08g, sodium 0.02g, magnesium 0.15g in macroelement;Iron 0.011g, iodine in trace element
0.00014g, zinc 0.007g;Vitamin A 0.0006g, beta carotene 0.000057g, vitamin D in liposoluble vitamin3
0.000001g, vitamin E 0.009g;Cobastab in water soluble vitamin10.001g, Cobastab20.001g, vitamin
B60.001g, Cobastab120.000002g, vitamin C 0.117g, pantothenic acid 0.003g, folic acid 0.000165g, nicotinic acid
0.0165g;Oatmeal 0.5g, buckwheat 0.5g, red bean powder 0.5g, carrot meal 0.5g, salmon 0.5g, snow pear powder 0.5g;Medicine
Food is with chrysanthemum 0.5g, sophora bud 0.5g, lotus leaf 0.56g, matrimony vine 0.5g, oyster 0.5g, emblic 0.5g, the root of kudzu vine in derived components
0.5g;L-cn 0.633g in natural plants compound;GABA 0.2g in new resource food.
Embodiment 2
Hypertension of pregnancy tailored version clinical nutrition formula of the present invention includes that PURE WHEY 11.3g, soybean separate
Albumen 4.33g, hydrolysis Isin glue collagen 0.66g, whole milk powder 12g, dried whole-egg 0.33g, colostrum 0.16, taurine 0.11g,
Ocean fish oligopeptide powder 0.266g;Olive oil 1.77g, soybean oil 4.48g, coconut oil 1.77g, perilla herb oil 2.64g, medium chain triglyceride
Three ester 0.213g;Maltodextrin 10.78g, rock sugar 8g, lactose 0.67g, tapioca 10g, resistant starch 13.33g;Meals are fine
Dimension selected from inulin, konjaku flour, galactooligosaccharide, FOS, oligoisomaltose, soybean polyoses, cyclodextrin, resistant dextrin,
At least one in fibre and soya, its gross mass be 4.99g, wherein water-soluble dietary fiber 3.83g, fat-soluble dietary fiber
1.16g;Calcium 0.4g, phosphorus 0.25g, potassium 0.08g, sodium 0.02g, magnesium 0.15g in macroelement;Iron 0.011g, iodine in trace element
0.00014g, zinc 0.007g;Vitamin A 0.0006g, beta carotene 0.000057g, vitamin D in liposoluble vitamin3
0.000001g, vitamin E 0.009g;Cobastab in water soluble vitamin10.001g, Cobastab20.001g, vitamin
B60.001g, Cobastab120.000002g, vitamin C 0.117g, pantothenic acid 0.003g, folic acid 0.000165g, nicotinic acid
0.0165g;Oatmeal 0.33g, buckwheat 0.33g, red bean powder 0.166g, carrot meal 0.166g, salmon 0.166g, snow pear
Powder 0.166g;Chrysanthemum 0.5g, sophora bud 0.5g, lotus leaf 0.56g, matrimony vine 0.5g, oyster 0.5g, emblic in integration of drinking and medicinal herbs composition
0.5g, root of kudzu vine 0.5g;L-cn 0.633g in natural plants compound;GABA 0.2g in new resource food.
Embodiment 3
Hypertension of pregnancy tailored version clinical nutrition formula of the present invention includes that PURE WHEY 11.3g, soybean separate
Albumen 4.33g, hydrolysis Isin glue collagen 0.66g, whole milk powder 12g, dried whole-egg 0.33g, colostrum 0.16, taurine 0.11g,
Ocean fish oligopeptide powder 0.266g;Olive oil 2.77g, soybean oil 4.48g, coconut oil 2.77g, perilla herb oil 0.64g, medium chain triglyceride
Three ester 0.213g;Maltodextrin 10.78g, rock sugar 10g, lactose 0.67g, tapioca 10g, resistant starch 13.33g;Meals are fine
Dimension selected from inulin, konjaku flour, galactooligosaccharide, FOS, oligoisomaltose, soybean polyoses, cyclodextrin, resistant dextrin,
At least one in fibre and soya, its gross mass be 4.99g, wherein water-soluble dietary fiber 3.83g, fat-soluble dietary fiber
1.16g;Calcium 0.4g, phosphorus 0.25g, potassium 0.08g, sodium 0.02g, magnesium 0.15g in macroelement;Iron 0.011g, iodine in trace element
0.00014g, zinc 0.007g;Vitamin A 0.0006g, beta carotene 0.000057g, vitamin D in liposoluble vitamin3
0.000001g, vitamin E 0.009g;Cobastab in water soluble vitamin10.001g, Cobastab20.001g, vitamin
B60.001g, Cobastab120.000002g, vitamin C 0.117g, pantothenic acid 0.003g, folic acid 0.000165g, nicotinic acid
0.0165g;Oatmeal 0.33g, buckwheat 0.33g, red bean powder 0.166g, carrot meal 0.166g, salmon 0.166g, snow pear
Powder 0.166g;Chrysanthemum 0.2g in integration of drinking and medicinal herbs composition, sophora bud 0.167g, lotus leaf 0.167g, matrimony vine 0.167g, oyster 0.167g,
Emblic 0.167g, root of kudzu vine 0.167g;L-cn 0.633g in natural plants compound;Gamma-amino fourth in new resource food
Sour 0.16g.
Embodiment 4
Hypertension of pregnancy tailored version clinical nutrition formula of the present invention includes that PURE WHEY 11.3g, soybean separate
Albumen 4.33g, hydrolysis Isin glue collagen 0.66g, whole milk powder 12g, dried whole-egg 0.33g, colostrum 0.16, taurine 0.11g,
Ocean fish oligopeptide powder 0.266g;Olive oil 2.77g, soybean oil 4.48g, coconut oil 2.77g, perilla herb oil 0.64g, medium chain triglyceride
Three ester 0.213g;Maltodextrin 10.78g, rock sugar 10g, lactose 0.67g, tapioca 10g, resistant starch 13.33g;Meals are fine
Dimension selected from inulin, konjaku flour, galactooligosaccharide, FOS, oligoisomaltose, soybean polyoses, cyclodextrin, resistant dextrin,
At least one in fibre and soya, its gross mass be 4.99g, wherein water-soluble dietary fiber 3.83g, fat-soluble dietary fiber
1.16g;Calcium 0.4g, phosphorus 0.25g, potassium 0.08g, sodium 0.02g, magnesium 0.15g in macroelement;Iron 0.011g, iodine in trace element
0.00014g, zinc 0.007g;Vitamin A 0.0006g, beta carotene 0.000057g, vitamin D in liposoluble vitamin3
0.000001g, vitamin E 0.009g;Cobastab in water soluble vitamin10.001g, Cobastab20.001g, vitamin
B60.001g, Cobastab120.000002g, vitamin C 0.117g, pantothenic acid 0.003g, folic acid 0.000165g, nicotinic acid
0.0165g;Oatmeal 0.33g, buckwheat 0.33g, red bean powder 0.166g, carrot meal 0.166g, salmon 0.166g, snow pear
Powder 0.166g;Chrysanthemum 0.1g, sophora bud 0.1g, lotus leaf 0.1g, matrimony vine 0.1g, oyster 0.1g, emblic in integration of drinking and medicinal herbs composition
0.1g, root of kudzu vine 0.1g;L-cn 0.633g in natural plants compound;GABA 0.16g in new resource food.
Embodiment 5
Hypertension of pregnancy tailored version clinical nutrition formula of the present invention includes that PURE WHEY 11.3g, soybean separate
Albumen 4.33g, hydrolysis Isin glue collagen 0.66g, whole milk powder 12g, dried whole-egg 0.33g, colostrum 0.16, taurine 0.11g,
Ocean fish oligopeptide powder 0.266g;Olive oil 2.77g, soybean oil 4.48g, coconut oil 2.77g, perilla herb oil 0.64g, medium chain triglyceride
Three ester 0.213g;Maltodextrin 10.98g, rock sugar 10g, lactose 0.67g, tapioca 10g, resistant starch 13.33g;Meals are fine
Dimension selected from inulin, konjaku flour, galactooligosaccharide, FOS, oligoisomaltose, soybean polyoses, cyclodextrin, resistant dextrin,
At least one in fibre and soya, its gross mass be 4.99g, wherein water-soluble dietary fiber 3.83g, fat-soluble dietary fiber
1.16g;Calcium 0.4g, phosphorus 0.25g, potassium 0.08g, sodium 0.02g, magnesium 0.15g in macroelement;Iron 0.011g, iodine in trace element
0.00014g, zinc 0.007g;Vitamin A 0.0006g, beta carotene 0.000057g, vitamin D in liposoluble vitamin3
0.000001g, vitamin E 0.009g;Cobastab in water soluble vitamin10.001g, Cobastab20.001g, vitamin
B60.001g, Cobastab120.000002g, vitamin C 0.117g, pantothenic acid 0.003g, folic acid 0.000165g, nicotinic acid
0.0165g;Oatmeal 0.33g, buckwheat 0.33g, red bean powder 0.166g, carrot meal 0.166g, salmon 0.166g, snow pear
Powder 0.166g;Chrysanthemum 0.1g, sophora bud 0.1g, lotus leaf 0.1g, matrimony vine 0.1g, oyster 0.1g, emblic in integration of drinking and medicinal herbs composition
0.1g, root of kudzu vine 0.1g;L-cn 0.633g in natural plants compound.
Embodiment 6
Hypertension of pregnancy tailored version clinical nutrition formula of the present invention includes that PURE WHEY 11.3g, soybean separate
Albumen 4.33g, hydrolysis Isin glue collagen 0.66g, whole milk powder 12g, dried whole-egg 0.33g, colostrum 0.16, taurine 0.11g,
Ocean fish oligopeptide powder 0.266g;Olive oil 2.77g, soybean oil 4.48g, coconut oil 2.77g, perilla herb oil 0.64g, medium chain triglyceride
Three ester 0.213g;Maltodextrin 11.48g, rock sugar 10g, lactose 0.67g, tapioca 10g, resistant starch 13.33g;Meals are fine
Dimension selected from inulin, konjaku flour, galactooligosaccharide, FOS, oligoisomaltose, soybean polyoses, cyclodextrin, resistant dextrin,
At least one in fibre and soya, its gross mass be 4.99g, wherein water-soluble dietary fiber 3.83g, fat-soluble dietary fiber
1.16g;Calcium 0.4g, phosphorus 0.25g, potassium 0.08g, sodium 0.02g, magnesium 0.15g in macroelement;Iron 0.011g, iodine in trace element
0.00014g, zinc 0.007g;Vitamin A 0.0006g, beta carotene 0.000057g, vitamin D in liposoluble vitamin3
0.000001g, vitamin E 0.009g;Cobastab in water soluble vitamin10.001g, Cobastab20.001g, vitamin
B60.001g, Cobastab120.000002g, vitamin C 0.117g, pantothenic acid 0.003g, folic acid 0.000165g, nicotinic acid
0.0165g;Oatmeal 0.33g, buckwheat 0.33g, red bean powder 0.166g, carrot meal 0.166g, salmon 0.166g, snow pear
Powder 0.166g;L-cn 0.633g in natural plants compound;GABA 0.16g in new resource food.
Embodiment 7
Hypertension of pregnancy tailored version clinical nutrition formula of the present invention includes that PURE WHEY 11.3g, soybean separate
Albumen 4.33g, hydrolysis Isin glue collagen 0.66g, whole milk powder 12g, dried whole-egg 0.33g, colostrum 0.16, taurine 0.11g,
Ocean fish oligopeptide powder 0.266g;Olive oil 2.77g, soybean oil 4.48g, coconut oil 2.77g, perilla herb oil 0.64g, medium chain triglyceride
Three ester 0.213g;Maltodextrin 11.64g, rock sugar 10g, lactose 0.67g, tapioca 10g, resistant starch 13.33g;Meals are fine
Dimension selected from inulin, konjaku flour, galactooligosaccharide, FOS, oligoisomaltose, soybean polyoses, cyclodextrin, resistant dextrin,
At least one in fibre and soya, its gross mass be 4.99g, wherein water-soluble dietary fiber 3.83g, fat-soluble dietary fiber
1.16g;Calcium 0.4g, phosphorus 0.25g, potassium 0.08g, sodium 0.02g, magnesium 0.15g in macroelement;Iron 0.011g, iodine in trace element
0.00014g, zinc 0.007g;Vitamin A 0.0006g, beta carotene 0.000057g, vitamin D in liposoluble vitamin3
0.000001g, vitamin E 0.009g;Cobastab in water soluble vitamin10.001g, Cobastab20.001g, vitamin
B60.001g, Cobastab120.000002g, vitamin C 0.117g, pantothenic acid 0.003g, folic acid 0.000165g, nicotinic acid
0.0165g;Oatmeal 0.33g, buckwheat 0.33g, red bean powder 0.166g, carrot meal 0.166g, salmon 0.166g, snow pear
Powder 0.166g;L-cn 0.633g in natural plants compound.
Embodiment 8
The preparation method of the nutrient powder of the formula of the hypertension of pregnancy tailored version clinical nutrition containing embodiment 1- embodiment 7 is such as
Under:
1) powdered oil is prepared:By the fat of predetermined weight with sucrose ester, monoglyceride, maltodextrin, water at 70 DEG C or so
Carry out mixed dissolution and prepare emulsion, the wherein consumption of sucrose ester and monoglyceride for emulsion weight 2.5%~5%, water
10~15 times for fat weight of consumption, maltodextrin consumption for emulsion weight 8%~20%;Above-mentioned emulsion is stirred
After 2~5min of mixing, carry out 2 emulsifying homogeneous under high pressure and process, the emulsifying homogeneous time is 12~18min;Then sprayed
Mist is dried, and prepares powdered oil with 60~80 mesh sieves point;
2) integration of drinking and medicinal herbs component powders are prepared:By the integration of drinking and medicinal herbs composition of predetermined weight be put into pulverizer carry out crushing, mistake
60~80 mesh sieves make integration of drinking and medicinal herbs component powders;
3) by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, trace element, the life of fat-soluble dimension
Element, water soluble vitamin, meals elite, natural plants compound and new resource food are prepared into particle diameter respectively for 100~300
μm powdery;
4) by step 1)~step 3) obtained by powder be well mixed, to obtain hypertension tailored version complete nourishing powder,
Filling after sterilization processing in sterilized packaging bag or it is placed directly within sterilized pail pack.
Aforesaid operations step is both needed to carry out under the protection of inert gas, and such as nitrogen protection, to prevent that powder is quick-fried
Fried danger.
Embodiment 9
The preparation method of the nutrition emulsion of the formula of the hypertension of pregnancy tailored version clinical nutrition containing embodiment 1- embodiment 7
As follows:
1) powdered oil is prepared:By the fat of predetermined weight with sucrose ester, monoglyceride, maltodextrin, water at 70 DEG C or so
Carry out mixed dissolution and prepare emulsion, the wherein consumption of sucrose ester and monoglyceride for emulsion weight 2.5%~5%, water
10~15 times for fat weight of consumption, maltodextrin consumption for emulsion weight 8%~20%;Above-mentioned emulsion is stirred
After 2~5min of mixing, carry out 2 emulsifying homogeneous under high pressure and process, the emulsifying homogeneous time is 12~18min;Then sprayed
Mist is dried, and prepares powdered oil with 60~80 mesh sieves point;
2) integration of drinking and medicinal herbs component powders are prepared:By the integration of drinking and medicinal herbs composition of predetermined weight be put into pulverizer carry out crushing, mistake
60~80 mesh sieves make integration of drinking and medicinal herbs component powders;
3) by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, trace element, the life of fat-soluble dimension
Element, water soluble vitamin, meals elite, natural plants compound and new resource food are prepared into particle diameter respectively for 100~300
μm powdery;
4) by step 3) in protein powder be dissolved in temperature be 20~25 DEG C, abundant water in the pure water of 280~350g
Change 3~15h, obtain in protein aqueous solution, then by step 3) in carbohydrate powder, macroelement powder, micro unit
Plain powder, water soluble vitamin powder are dissolved in protein aqueous solution, carry out gentle agitation, add emulsifying agent and thickener,
The aqueous phase solution being uniformly mixed;
5) by step 1) in micro-capsule embedding treatment after fat powder, step 2) in prepare liposoluble vitamin powder
End, meals elite powder, integration of drinking and medicinal herbs component powders, natural plants compound powder sequentially add the water phase of gained in step 4
Solution, and strong agitation is carried out, the concentrated emulsions being uniformly mixed;
6) in the concentrated emulsions described in step 5,20~25 DEG C, are added, the pure water of 100~170g is stirred, while going
The foam of skim-coat, obtains emulsion, then by emulsion under 300-500Bar homogeneous, homogenisation cycle number of times be 2-4 time, Ran Hou
Sterilize at 110~130 DEG C, be cooled to room temperature, nutrition emulsion is obtained, and by filling for nutrition emulsion in sterilized packaging bag.
Aforesaid operations step is both needed to carry out under the protection of inert gas, and such as nitrogen protection, to prevent that powder is quick-fried
Fried danger.
Hypertension experiment 1
The experiment of this hypertension is carried out with the nutrient powder prepared according to embodiment 1~7 for blank group.
SPF levels Healthy female Wistar rats 130, are randomly divided into normal group 10, hypertension group 120;Male 35
Only.Mouse Oestrous Cycle is determined using vaginal smear method, in emotionally front and Wistar male rats 1:1 mates, and secondary daily inspection is female
Mouse introitus and bedding and padding, and make vaginal smear detection, observe cloudy bolt and vaginal smear sperm, it is determined as pregnant 0d.Determine pregnant
It is pregnent after starting to raise 14 days, hypertension of pregnancy group is injected intravenously 1.0 μ g of endotoxin per kg body weight, normal group feeds normally to raise
Material, once a day, totally 4 days.
After gestation is determined, hypertension group chooses hypertension of pregnancy rat 64 according to order of becoming pregnant, and is divided into 8 groups successively
(control group, 1~embodiment of embodiment 7), 8 per group.In after gestation the 10th day, 7 groups of 1~embodiment of embodiment was according to agent
Amount 500mg/kg/day gavages, blank group give normal diet, and 2 times a day, raise 2 weeks.Control group chooses 8 according to order of becoming pregnant
Only, chow diet nursing is awarded.From the beginning of the 10th day, arteria caudalis is measured using BP-6 animal non-invasive blood pressures measuring system every 2d
Pressure, blood pressure result represent (mean arterial pressure=systolic pressure/3+2* diastolic pressure/3) using mean arterial pressure.Measurement data is used
SPSS19 software processings, experimental data x ± s represent that (a is represented and compared significant difference, P with normal group<0.05;* represent and right
Significant difference, P are compared according to group<0.05;* is represented and is compared significant difference, P with control group<0.01).
Each group rat blood pressure (0d) before 1 formula feeding of table
Table 2 is continuously fed with each formula 14 days, the testing result of rat blood pressure
From Tables 1 and 2, after feeding in 14 days, compared with control group, the mean arterial pressure of 1~7 group of enforcement has
(a is represented and is compared significant difference, P with normal group for conspicuousness decline<0.05;* representing, significant difference, P is compared with control group<
0.05;* is represented and is compared significant difference, P with control group<0.01), that is, implementing 1~7 nutrient powder for preparing has drop in various degree
The effect of low pregnant mouse blood pressure.
Hypertension experiment 2
The experiment of this hypertension is carried out for nutrient powder prepared by contrast groups and embodiment 1.
A kind of health food for treating the hypertension of pregnancy that contrast groups are prepared using Chinese patent CN103005409A, its are former
Material includes chicken, starch, cabbage heart, chrysanthemum tea, jasmine tea, rice and dispensing (cooking wine and salt).
Using the experimental procedure in hypertension experiment 1, SPF level Healthy female Wistar rats, determine that the hypertension of pregnancy is little
Mouse, according to becoming pregnant, order chooses hypertension of pregnancy mouse 20, is divided into each group successively, 10 per group, opens within the 10th day after gestation
Begin, contrast groups, embodiment 1 are according to dosage 500mg/kg/day gavages.From the beginning of the 10th day, using BP-6 animal non-invasive blood pressures
Measuring system measures tail arterial blood pressure, and blood pressure result is represented using mean arterial pressure., using mean value, its result is such as measurement data
Described in table 3.
Table 3 is continuously fed with each formula 14 days, the testing result of rat blood pressure
After feeding in 14 days, understand that according to table 3 the mean arterial pressure rate of rise of nutrient powder prepared by embodiment 1 is slightly below
The blood pressure lowering effect of nutrient powder prepared by contrast groups 1, i.e. embodiment 1 is slightly better than contrast groups, but contrast groups can not be that gestation is high
Blood pressure patient provides comprehensive nutritional support, such as trace element, new resource food etc..
From above-described embodiment, in hypertension of pregnancy tailored version clinical nutrition formula of the present invention, various components are mutual
It is engaged, there is provided the suitable energy and various critical nutrients needed for pregnancy-induced hypertension patients, there is provided completely required micro
Nutrient content, while by adding the integration of drinking and medicinal herbs composition with blood pressure reduction effect, natural plants compound and new resource food,
By above-mentioned experimental data, each component reasonable mixture ratio, shows that hypertension of pregnancy tailored version clinical nutrition formula of the present invention is fed
After raising SPF level Wistar hypertension pregnant mouses, blood pressure has conspicuousness to decline, and which can aid in the blood pressure for reducing the hypertension of pregnancy
Value, reduces the risk of the hypertension of pregnancy, it is ensured that needed for the growth of fetus and normal development.
Above the specific embodiment of the present invention is described in detail, but which has been only used as example, the present invention has been not intended to limit
In particular embodiments described above.To those skilled in the art, any equivalent modifications carried out by the practicality and replace
In generation, is also all among scope of the invention.Therefore, the equalization that is made without departing from the spirit and scope of the invention is converted and is repaiied
Change, should all cover within the scope of the invention.
Claims (9)
1. a kind of hypertension of pregnancy tailored version clinical nutrition is filled a prescription, it is characterised in that including the component of following parts by weight:25-
35 parts of protein, 8-15 parts fat, 35-45 part carbohydrate, 3-8 part dietary fibers, 0.6-1.2 part macroelements, 0.01-
0.03 part of trace element, 0.005-0.02 part liposoluble vitamins, 0.08-0.2 part water soluble vitamins, 0.5-5 parts meals essence
China, 0.5-5 part integration of drinking and medicinal herbs compositions, 0.1-1 part natural plants compounds and 0.1-0.4 part new resource foods;
Wherein, the integration of drinking and medicinal herbs composition in chrysanthemum, the sophora bud, lotus leaf, matrimony vine, oyster, emblic, the root of kudzu vine at least one
Kind;
Wherein, the meals elite is selected from cereal, beans, potato class, greengrocery, Homonemeae, nut-seed class, fish and shrimp, poultry
At least one in meat, fruits.
2. a kind of hypertension of pregnancy tailored version clinical nutrition according to claim 1 is filled a prescription, it is characterised in that the meals
Elite is oatmeal, buckwheat, red bean powder, carrot meal, salmon powder, snow pear powder.
3. a kind of hypertension of pregnancy tailored version clinical nutrition according to claim 1 is filled a prescription, it is characterised in that the new money
Source food is selected from first milk basic protein, GABA, chitosan oligosaccharide, eucommia Bark male flower, bamboo-leaves flavones, CPP, oat
At least one in beta glucan, yeast beta-dextran, leaf of Moringa, xylo-oligosaccharide.
4. a kind of hypertension of pregnancy tailored version clinical nutrition according to claim 1 is filled a prescription, it is characterised in that described natural
Plant compound selected from l-cn, Glucosamine, FOS, lutein, phytosterol, lycopene, resveratrol,
At least one in allicin.
5. a kind of hypertension of pregnancy tailored version clinical nutrition according to claim 1 is filled a prescription, it is characterised in that the medicine food
Parts by weight with each component in derived components are as follows:Chrysanthemum 0-1 parts, sophora bud 0-1 parts, lotus leaf 0-1 parts, matrimony vine 0-1 parts, oyster 0-
1 part, emblic 0-1 parts, root of kudzu vine 0-1 parts.
6. a kind of hypertension of pregnancy tailored version clinical nutrition according to claim 1 is filled a prescription, it is characterised in that the albumen
The good protein weight provided in matter and amino acid accounts for more than the 70% of gross protein weight.
7. a kind of hypertension of pregnancy tailored version clinical nutrition according to claim 1 is filled a prescription, it is characterised in that the fat
The ratio of middle n-6 aliphatic acid and n-3 aliphatic acid is 3~4:1.
8. the preparation method that a kind of hypertension of pregnancy tailored version clinical nutrition as claimed in claim 1 is filled a prescription, it is characterised in that
The fat makes powder using micro-capsule embedding techniques, and the integration of drinking and medicinal herbs composition is by crushing, sieving and make powder.
9. preparation method according to claim 8, it is characterised in that the mesh number that the integration of drinking and medicinal herbs composition sieves is 60-
80 mesh.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611209082.6A CN106490605A (en) | 2016-12-23 | 2016-12-23 | A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611209082.6A CN106490605A (en) | 2016-12-23 | 2016-12-23 | A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106490605A true CN106490605A (en) | 2017-03-15 |
Family
ID=58333777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611209082.6A Pending CN106490605A (en) | 2016-12-23 | 2016-12-23 | A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106490605A (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106858595A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | One kind burn tailored version clinical nutrition formula and preparation method thereof |
CN106858620A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof |
CN106942748A (en) * | 2017-03-29 | 2017-07-14 | 上海奥医生物医药科技有限公司 | A kind of female acyesis tailored version clinical nutrition formula and preparation method thereof |
CN106962912A (en) * | 2017-03-29 | 2017-07-21 | 上海奥医生物医药科技有限公司 | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof |
CN106983136A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof |
CN106983151A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of inflammatory bowel disease tailored version clinical nutrition formula and preparation method thereof |
CN107212423A (en) * | 2017-05-16 | 2017-09-29 | 柳州放心源农业有限公司 | A kind of hypertension nutraceutical |
CN107319525A (en) * | 2017-06-29 | 2017-11-07 | 上海复旦奥医医学科技有限公司 | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof |
CN107319524A (en) * | 2017-06-29 | 2017-11-07 | 上海复旦奥医医学科技有限公司 | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof |
CN107373672A (en) * | 2017-08-23 | 2017-11-24 | 上海奥医生物医药科技有限公司 | A kind of irregular menstruation women tailored version clinical nutrition formula and preparation method thereof |
CN107440102A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof |
CN107440121A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of Single Obesity tailored version clinical nutrition formula and preparation method thereof |
CN107616490A (en) * | 2017-08-23 | 2018-01-23 | 上海奥医生物医药科技有限公司 | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof |
CN108077911A (en) * | 2017-12-13 | 2018-05-29 | 上海奥医生物医药科技有限公司 | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof |
CN108669540A (en) * | 2018-05-10 | 2018-10-19 | 上海奥医生物医药科技有限公司 | Cerebral apoplexy tailored version clinical nutrition formula and preparation method thereof |
CN110800996A (en) * | 2019-11-07 | 2020-02-18 | 上海奥医高科技实业有限公司 | Special clinical nutrition formula for vomiting of pregnancy and preparation method thereof |
CN112602928A (en) * | 2020-12-18 | 2021-04-06 | 湖州草本连生物科技有限公司 | Nutritional powder with effects of lowering blood pressure, reducing blood lipid and lowering blood sugar, and its preparation method |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105520151A (en) * | 2016-01-26 | 2016-04-27 | 青岛森淼实业有限公司 | Fruit and vegetable protein powder nutrition supplement and preparation method thereof |
CN105533705A (en) * | 2015-12-27 | 2016-05-04 | 劲膳美生物科技股份有限公司 | Medical formula food for recuperating women during second trimester |
CN105901725A (en) * | 2016-04-21 | 2016-08-31 | 九沪(上海)生物科技有限公司 | Health-caring nutritional powder and preparation method of same |
CN106036420A (en) * | 2016-06-24 | 2016-10-26 | 甘洛县彝家山寨农牧科技有限公司 | Tartary buckwheat health care food applicable to diabetics and preparation method thereof |
CN106174585A (en) * | 2016-06-30 | 2016-12-07 | 山东凤凰生物有限公司 | Hypoglycemic compositions and hypoglycemic compound probiotic spy's dietary seafood |
-
2016
- 2016-12-23 CN CN201611209082.6A patent/CN106490605A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105533705A (en) * | 2015-12-27 | 2016-05-04 | 劲膳美生物科技股份有限公司 | Medical formula food for recuperating women during second trimester |
CN105520151A (en) * | 2016-01-26 | 2016-04-27 | 青岛森淼实业有限公司 | Fruit and vegetable protein powder nutrition supplement and preparation method thereof |
CN105901725A (en) * | 2016-04-21 | 2016-08-31 | 九沪(上海)生物科技有限公司 | Health-caring nutritional powder and preparation method of same |
CN106036420A (en) * | 2016-06-24 | 2016-10-26 | 甘洛县彝家山寨农牧科技有限公司 | Tartary buckwheat health care food applicable to diabetics and preparation method thereof |
CN106174585A (en) * | 2016-06-30 | 2016-12-07 | 山东凤凰生物有限公司 | Hypoglycemic compositions and hypoglycemic compound probiotic spy's dietary seafood |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106858595A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | One kind burn tailored version clinical nutrition formula and preparation method thereof |
CN106858620A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof |
CN106942748A (en) * | 2017-03-29 | 2017-07-14 | 上海奥医生物医药科技有限公司 | A kind of female acyesis tailored version clinical nutrition formula and preparation method thereof |
CN106962912A (en) * | 2017-03-29 | 2017-07-21 | 上海奥医生物医药科技有限公司 | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof |
CN106983136A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof |
CN106983151A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of inflammatory bowel disease tailored version clinical nutrition formula and preparation method thereof |
CN107212423A (en) * | 2017-05-16 | 2017-09-29 | 柳州放心源农业有限公司 | A kind of hypertension nutraceutical |
CN107319525A (en) * | 2017-06-29 | 2017-11-07 | 上海复旦奥医医学科技有限公司 | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof |
CN107319524A (en) * | 2017-06-29 | 2017-11-07 | 上海复旦奥医医学科技有限公司 | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof |
CN107373672A (en) * | 2017-08-23 | 2017-11-24 | 上海奥医生物医药科技有限公司 | A kind of irregular menstruation women tailored version clinical nutrition formula and preparation method thereof |
CN107440102A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof |
CN107440121A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of Single Obesity tailored version clinical nutrition formula and preparation method thereof |
CN107616490A (en) * | 2017-08-23 | 2018-01-23 | 上海奥医生物医药科技有限公司 | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof |
CN108077911A (en) * | 2017-12-13 | 2018-05-29 | 上海奥医生物医药科技有限公司 | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof |
CN108669540A (en) * | 2018-05-10 | 2018-10-19 | 上海奥医生物医药科技有限公司 | Cerebral apoplexy tailored version clinical nutrition formula and preparation method thereof |
CN110800996A (en) * | 2019-11-07 | 2020-02-18 | 上海奥医高科技实业有限公司 | Special clinical nutrition formula for vomiting of pregnancy and preparation method thereof |
CN112602928A (en) * | 2020-12-18 | 2021-04-06 | 湖州草本连生物科技有限公司 | Nutritional powder with effects of lowering blood pressure, reducing blood lipid and lowering blood sugar, and its preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106490605A (en) | A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof | |
CN106666728A (en) | Special clinical nutrient composition for gestational diabetes and preparation method of nutrient composition | |
CN106579393A (en) | Special clinical nutrient formula for diabetes and preparation method thereof | |
CN106858620A (en) | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof | |
CN106983136A (en) | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof | |
CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
CN107927754A (en) | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production | |
CN108651988A (en) | Nephrosis dialysis tailored version clinical nutrition formula and preparation method thereof | |
CN106616615A (en) | Clinical nutrient formula special for tumor and preparation method of clinical nutrient formula | |
CN106962912A (en) | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof | |
JP2004159637A (en) | Dietary composition | |
CN103815282B (en) | Preparation method for sea cucumber wheaten food | |
CN107440120A (en) | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof | |
CN108634324A (en) | A kind of special diet food and preparation method thereof promoting cesarean lactation and nutritional supplementation | |
CN108013453A (en) | Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof | |
CN106579460A (en) | Special clinical nutrition formula for fracture and preparation method thereof | |
CN107319524A (en) | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof | |
CN108077911A (en) | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof | |
CN107616490A (en) | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof | |
CN108013452A (en) | A kind of puerperal abdominal flatulence gas tailored version clinical nutrition formula and preparation method thereof | |
CN108669540A (en) | Cerebral apoplexy tailored version clinical nutrition formula and preparation method thereof | |
CN110074397A (en) | A kind of upgrowth and development of children tailored version clinical nutrition formula and preparation method thereof | |
CN108703365A (en) | Protein allergy tailored version clinical nutrition formula and preparation method thereof | |
CN105685254A (en) | Meatless sausage containing dietary fibers and processing process of meatless sausage | |
CN101422239A (en) | Combined partner capable of increasing edible rice, flour nutrition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170315 |
|
RJ01 | Rejection of invention patent application after publication |